The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Laboratoire Francais Du Fractionnement Et Des Biotechnologies Societe Anonyme competitive analysis

Loading summary...

Latest patents of Laboratoire Francais Du Fractionnement Et Des Biotechnologies Societe Anonyme opposed by its competitors

Explore Laboratoire Francais Du Fractionnement Et Des Biotechnologies Societe Anonyme's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2345425
Jul 11, 2018Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs2

Latest PTAB cases involving Laboratoire Francais Du Fractionnement Et Des Biotechnologies Societe Anonyme

Discover the latest PTAB cases involving Laboratoire Francais Du Fractionnement Et Des Biotechnologies Societe Anonyme, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Laboratoire Francais Du Fractionnement Et Des Biotechnologies Societe Anonyme with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES SOCIETE ANONYME - 2 - -
OCTAPHARMA78 - -
TAKEDA PHARMACEUTICALS3 - - -